Trials

In this section you will find planned, ongoing and completed paediatric clinical trials with the contribution of GermanNetPaeT.

c4c non-industry / academic "Proof-of-Viability" trials

 

Steroids to Treat Kawasaki Disease: KD-CAAP will assess the effectiveness of adding steroids to standard treatment in children with Kawasaki Disease, and aims to recruit 262 children as part of the study (Leads: Dr. Despina Eleftheriou and Prof Paul Brogan of the University College of London (UCL), an academic research institution in the UK).

For more information about the research study, contact: Despina Eleftheriou d.eleftheriou@ucl.ac.uk

 

Posaconazole in Children with Cystic Fibrosis: cASPerCF will assess the dose of posaconazole in children and young people with Cystic Fibrosis and infection with Aspergillus and aims to recruit 130 children as part of the study (Lead: Prof. Adilia Warris of the MRC Centre for Medical Mycology, University of Aberdeen and Ospedale Pediatrico Bambino Gesù (OPBG), a children’s hospital in Rome, Italy). 

For more information about the research study, contact: Adilia Warris a.warris@abdn.ac.uk

 

Paracetamol in Premature Babies: TREOCAPA will assess the effectiveness of paracetamol in premature babies with a patent ductus arteriosus, and aims to recruit around 600 babies as part of the study (Lead: Prof. Jean-Christophe Roze of INSERM, a public research organization in Paris, France entirely dedicated to human health)

For more information about the research study, contact: Jean Christophe Roze jcroze@chu-nantes.fr

 

https://conect4children.org/news/press-release-launch-of-the-non-industries-study/

Contribution of German study centres

KD-CAAP: Steroids to Treat Kawasaki Disease

cASPerCF: Posaconazole in Children with Cystic Fibrosis